Detalhe da pesquisa
1.
Antibacterial Envelope to Prevent Cardiac Implantable Device Infection.
N Engl J Med
; 380(20): 1895-1905, 2019 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30883056
2.
R-wave sensing in an implantable cardiac monitor without ECG-based preimplant mapping: results from a multicenter clinical trial.
Pacing Clin Electrophysiol
; 37(4): 505-11, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24299115
3.
Mortality Benefit Among Primary Prevention Implantable Cardioverter Defibrillator Recipients on Contemporary Heart Failure Treatment.
JACC Clin Electrophysiol
; 2024 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38520434
4.
Low-temperature electrocautery reduces adverse effects from secondary cardiac implantable electronic device procedures: Insights from the WRAP-IT trial.
Heart Rhythm
; 18(7): 1142-1150, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33781980
5.
Additional antitachycardia pacing programming strategies further reduce unnecessary implantable cardioverter-defibrillator shocks.
Heart Rhythm
; 17(1): 98-105, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31369873
6.
Cost-Effectiveness of an Antibacterial Envelope for Cardiac Implantable Electronic Device Infection Prevention in the US Healthcare System From the WRAP-IT Trial.
Circ Arrhythm Electrophysiol
; 13(10): e008503, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32915063
7.
Cryoballoon-to-Pulmonary Vein Occlusion Assessment via Capnography Technique: Where Does Occlusion Testing by End-Tidal CO2 Measurement "Fit" as a Predictor of Long-Term Efficacy?
J Atr Fibrillation
; 11(1): 2055, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30455840
8.
Azithromycin Causes a Novel Proarrhythmic Syndrome.
Circ Arrhythm Electrophysiol
; 10(4)2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28408648
9.
Feedback to providers improves evidence-based implantable cardioverter-defibrillator programming and reduces shocks.
Heart Rhythm
; 12(3): 545-553, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25460168